Shares of Inovio Pharmaceuticals fell by a staggering 33.63% in 30 days from $10.13 to $6.72 at 11:17 EST on Friday, following last session’s upward trend. NASDAQ Composite is rising 0.96% to $13,951.11, following last session’s downward trend,

Inovio Pharmaceuticals’s last close was $9.16, 402.83% under its 52-week high of $33.79.

Inovio Pharmaceuticals’s Sales

Inovio Pharmaceuticals’s sales growth is a negative 35.9% for the present quarter and 237.1% for the next. The company’s growth estimates for the ongoing quarter and the next is 30.8% and 77.1%, respectively.

Inovio Pharmaceuticals’s Revenue

Year-on-year quarterly revenue growth grew by 1896.7%, now sitting on 7.41M for the twelve trailing months.

Inovio Pharmaceuticals’s Stock Yearly Top and Bottom Value

Inovio Pharmaceuticals’s stock is valued at $6.72 at 11:17 EST, way under its 52-week high of $33.79 and higher than its 52-week low of $6.49.

Inovio Pharmaceuticals’s Moving Average

Inovio Pharmaceuticals’s value is way under its 50-day moving average of $10.61 and way below its 200-day moving average of $11.28.

More news about Inovio Pharmaceuticals.

LEAVE A REPLY

Please enter your comment!
Please enter your name here